The following table provides a summary of available brand doses and how they are administered: | Brand Name | Active Ingredient | Available Doses | How Its Taken | |------------|-------------------|------------------------------------------------|------------------| | Saxenda | Liraglutide | 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg, 3.0 mg | Daily injection | | Victoza | Liraglutide | 0.6 mg, 1.2 mg, 1.8 mg | Daily injection | | Ozempic | Semaglutide | 0.25 mg, 0.5 mg, 1 mg, 2 mg | Weekly injection | | Wegovy | Semaglutide | 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg | Weekly injection | | Rybelsus | Semaglutide | 3 mg, 7 mg, 14 mg | Daily tablet | Practical tradeoffs, stated plainly
No coupon needed This is the final price (No hidden fees ever)
Who may be a candidate for Cerebrolysin therapy
Primary outcomes Risk of colorectal cancer All seven included studies discussed the colorectal cancer risk as an outcome among patients receiving GLP-1 RAs